There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with ...

Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...

Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by ...

By Nancy Lapid April 22 (Reuters) - Twice as many advanced pancreas cancer patients who received an experimental drug ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that detailed results from the ...

Results are in from an early trial of an MRNA-based vaccine to fight pancreatic cancer.

Theriva Biologics to present additional data from VIRAGE phase 2b trial of VCN-01 in metastatic pancreatic cancer at AACR 2026 meeting: Rockville, Maryland Monday, April 20, 2026, ...

Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by ...

Detailed price information for Theriva Biologics Inc (TOVX-A) from The Globe and Mail including charting and trades.

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data from two ...

We are once again proud to join the Lustgarten Foundation in raising awareness and funds for critical pancreatic cancer research. CBS News New York's Jenna DeAngelis served as emcee of the annual walk ...